Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
HCWBHCW Biologics Inc.
| Figure | HCWBHCW Biologics Inc.FY2025 · Dec |
|---|---|
| Revenue | $54.23K |
| Revenue, yoy | −97.9% |
| Net income | $7.96M |
| Net income, yoy | +73.5% |
| Net margin | -14,677.1% |
| Free cash flow | $13.39M |
| FCF margin | -24,693.2% |
| EPS, diluted | $10.63 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed